A carregar...
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
Use of highly pure antigens to improve vaccine safety has led to reduced vaccine immunogenicity and efficacy. This has led to the need to use adjuvants to improve vaccine immunogenicity. The ideal adjuvant should maximize vaccine immunogenicity without compromising tolerability or safety. Unfortunat...
Na minha lista:
| Publicado no: | Drug Saf |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4615573/ https://ncbi.nlm.nih.gov/pubmed/26446142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-015-0350-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|